Aquí está el episodio de mayo #TooMore 😋

Este mes, la Dra. Angela Lamarca
y el Dr. Alejandro Forner 🩺 comentan un par de estudios sobre el #hepatocarcinoma , uno para estadios iniciales y otro para intermedios 🤔

¿Quieres conocer más detalles?⬇️

transworldeditors.com/toomore-podcast

Necesitamos mas #investigacion para poder ofrecer a nuestros #pacientes las mejores opciones de #tratamiento

🧬🎯🧫🙌🏻

Fundación Jiménez Díaz SEOM Grupo Español de Tratamiento de Tumores Digestivos

So important to take into account all available information at the time of making #treatment decisions, including, of course, #molecular data!
🧬🎯🙌🏻

Calling all early-career physicians and scientists passionate about advancing NET research!
Join us for the NextGEN ENETS Scientific Workshop in Seville, Spain, from 30 Oct to 1 Nov 2024.
Applications for grants now open until 20 June - so don't miss out! enets.org/grant/nextgen-…

.⁦ESMO - Eur. Oncology⁩ is launching a monthly virtual journal club. 3 papers discussed during 1h by the best experts. The goal is to update all colleagues about the latest advances wherever they are in the 🌍. First session on May ! Stay connected ! esmo.org/about-esmo-mee…

The final version of our recommendations to maximise the value of tissue to guide treatment when reporting intrahepatic cholangiocarcinoma have just been published AMMF Cholangiocarcinoma Foundation doi.org/10.1016/j.jhep…...

Great news from The START Center at Fundación Jiménez Díaz

A big #StepForward for #CancerImmunotherapy while making #access to #InnovativeTreatments a reality for patients with #GastrointestinalCancers at Fundación Jiménez Díaz

👏🏻👏🏻
Victor Moreno Manuel Pedregal Carlos Lacalle MD SEOM Grupo Español de Tratamiento de Tumores Digestivos

Hablemos de #hepatocarcinoma
👇

Fundación Jiménez Díaz

Great opportunity to remind everyone of these ENS-CCA - Cholangiocarcinoma Foundation #Mentorship programs

🙌🏻

Day 3 of Cholangiocarcinoma Foundation #ccfac24 started strong with a panel of worldwide 🌍 #RegulatoryAgencies discussing #DrugApproval in #RareCancers

Patients🤝Clinicians🤝Regulators
#TOGETHER

🗺️ Harmonisation is a must
💡Innovative approaches
⏳Timing has to improve

FDA Oncology EU Medicines Agency

Closing day 2 of the Cholangiocarcinoma Foundation #ccfac24 with a deep dive into #RationalCombinations for treatment of #CCA

👉Get ready for Day 3 😉

#Oral presentations at #ccfac24 on some of the 🔝 #AcademicResearch ongoing in the field were presented today.

1. Towards early diagnosis: liquid biopsy DNA methylation
2. Immunotherapy markers from single-cell analysis
3. GWAS for genetic susceptibility

Mitesh Borad, M.D.

Congratulations Dr Kelley!!

Very much deserved 🫶

#Research is #Hope and how we are moving #forward . There are many ongoing #TrialsInProgress presented at #ccfac24 .

Mitesh Borad, M.D. Angela Lamarca

Part 2/2

#Research is #Hope and how we are moving #forward . There are many ongoing #TrialsInProgress presented at #ccfac24 . Part 1/2

Mitesh Borad, M.D. Angela Lamarca

Targeted therapies also moving forward with new data presented at #ccfac24 .

🟩Understanding natural history of #IDH1 mutated #CCA from the #EvIDHence study.

🟩Quality of life with targeted therapies: example of #zanidatamab .

Mitesh Borad, M.D. Angela Lamarca

#HotTopics in #TargetedTherapies also covered at #ccfac2024 .

👉🏼Resistance to FGFR inhibitors: #tinengotinib

👉🏼New targets: #brigimadlin for #MDM2 amplification

The future looks brighter. #CCAhope

Angela Lamarca Mitesh Borad, M.D.

“Long-term survivors in #CCA and #BiliaryMalignancies are becoming a #reality ”, indeed.

😊